pyrazines has been researched along with salmeterol xinafoate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Arditi, M; Arumugaswami, V; Bahar, I; Chan, SY; Chen, F; Cheng, MH; Garcia, G; Gomez, AC; Liu, B; Pei, F; Porritt, RA; Schurdak, ME; Shi, Q; Stern, AM; Taylor, DL; Vogt, A | 1 |
1 other study(ies) available for pyrazines and salmeterol xinafoate
Article | Year |
---|---|
A systems-level study reveals host-targeted repurposable drugs against SARS-CoV-2 infection.
Topics: Angiotensin-Converting Enzyme 2; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Chlorocebus aethiops; COVID-19; COVID-19 Drug Treatment; Drug Evaluation, Preclinical; Drug Repositioning; HEK293 Cells; Host-Pathogen Interactions; Humans; Imidazoles; Pyrazines; Salmeterol Xinafoate; SARS-CoV-2; Vero Cells; Virus Internalization | 2021 |